Mr Matthias Hellberg-Naegele speaks to ecancer at ESMO 2023 about CAR-T therapy and impact to patient outcomes and experience of treatment.
They outline key findings from real-word data and case studies about the impact of CAR-T therapies.
Mr Hellberg-Naegele concludes by providing an overall message to other healthcare professionals.